{"id":"https://openalex.org/W1958285261","doi":null,"title":"[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System].","display_name":"[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System].","publication_year":1998,"publication_date":"1998-03-31","ids":{"openalex":"https://openalex.org/W1958285261","mag":"1958285261","pmid":"https://pubmed.ncbi.nlm.nih.gov/9608114"},"language":"es","primary_location":{"id":"pmid:9608114","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9608114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atencion primaria","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004503196","display_name":"Rafael Cuena","orcid":"https://orcid.org/0000-0002-3091-6955","observed_orcids":["https://orcid.org/0000-0002-3091-6955"]},"institutions":[{"id":"https://openalex.org/I4210111854","display_name":"Hospital Virgen de la Salud","ror":"https://ror.org/0289cxp23","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111854","https://openalex.org/I4210141158","https://openalex.org/I4210163156","https://openalex.org/I4392738192"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R Cuena Boy","raw_affiliation_strings":["Unidad de Farmacolog\u00eda Cl\u00ednica, Hospital Virgen de la Salud de Toledo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unidad de Farmacolog\u00eda Cl\u00ednica, Hospital Virgen de la Salud de Toledo","institution_ids":["https://openalex.org/I4210111854"]}]},{"author_position":"last","author":{"id":null,"display_name":"M A Maci\u00e1 Mart\u00ednez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Maci\u00e1 Mart\u00ednez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.07943067,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"21","issue":"5","first_page":"289","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metoclopramide","display_name":"metoclopramide","score":0.9470000267028809},{"id":"https://openalex.org/keywords/clebopride","display_name":"clebopride","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9610000252723694},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6869999766349792},{"id":"https://openalex.org/keywords/antispasmodic-agents","display_name":"antispasmodic agents","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C2778479196","wikidata":"https://www.wikidata.org/wiki/Q421095","display_name":"Metoclopramide","level":3,"score":0.9675266742706299},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7009665369987488},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5731927156448364},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5716134309768677},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5253971219062805},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.5031628012657166},{"id":"https://openalex.org/C2780616385","wikidata":"https://www.wikidata.org/wiki/Q1385411","display_name":"Extrapyramidal symptoms","level":4,"score":0.4433368146419525},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.4218188226222992},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4066564738750458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37292730808258057},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16379493474960327},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.04359433054924011},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000932","descriptor_name":"Antiemetics","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003627","descriptor_name":"Data Interpretation, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005116","descriptor_name":"Extrapyramidal Tracts","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008787","descriptor_name":"Metoclopramide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9608114","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9608114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atencion primaria","raw_type":"Comparative Study"},{"id":"mag:1958285261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9608114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2394377538","https://openalex.org/W2408859935","https://openalex.org/W2392146086","https://openalex.org/W1792617866","https://openalex.org/W2402308704","https://openalex.org/W2094161736","https://openalex.org/W2463940400","https://openalex.org/W2413836749","https://openalex.org/W2271790791","https://openalex.org/W2437537872"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"clarify":[2],"if":[3],"there":[4,108],"is":[5,117],"any":[6],"basis":[7,119],"for":[8,120],"the":[9,42,121],"hypothesis":[10,122],"that":[11,123],"Clebopride":[12,60,80,124],"leads":[13],"to":[14,41,54,79,85,100,106,134],"more":[15,126],"extrapyramidal":[16,110,127],"reactions":[17,78,99,128],"than":[18,129],"Metoclopramide.":[19,130],"DESIGN:":[20],"Observational,":[21],"longitudinal,":[22],"retrospective":[23],"and":[24,66,81,102],"comparative":[25],"study":[26,137],"of":[27,30,75,83,96,104],"two":[28],"series":[29],"cases.":[31],"SETTING:":[32],"The":[33],"entire":[34],"Spanish":[35,43],"healthcare":[36],"system.":[37],"PATIENTS:":[38],"Those":[39],"notified":[40],"Drug":[44],"watch":[45],"system":[46],"as":[47],"possibly":[48],"having":[49],"suffered":[50],"an":[51],"adverse":[52,77,98],"reaction":[53],"Metoclopramide":[55,86,101],"(n":[56,61],"=":[57,62,113],"98)":[58],"or":[59],"123)":[63],"between":[64],"1/1/1990":[65],"10/6/1997.":[67],"INTERVENTIONS:":[68],"None.":[69],"MEASUREMENTS":[70],"AND":[71],"MAIN":[72],"RESULTS:":[73],"84.3%":[74],"suspected":[76,97],"51.6%":[82],"those":[84,105],"had":[87],"a":[88,118,136],"non-hospital":[89],"precedence":[90],"(P":[91,112],"<":[92],"0.001).":[93],"In":[94],"48.0%":[95],"72.4%":[103],"Clebopride,":[107],"was":[109,132],"toxicity":[111],"0.021).":[114],"CONCLUSIONS:":[115],"There":[116],"causes":[125],"It":[131],"reasonable":[133],"realize":[135],"based":[138],"on":[139],"this":[140],"hypothesis.":[141]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}